Insulet
PODD
622 hedge funds and large institutions have $16.5B invested in Insulet in 2024 Q3 according to their latest regulatory filings, with 91 funds opening new positions, 225 increasing their positions, 237 reducing their positions, and 63 closing their positions.
44% more first-time investments, than exits
New positions opened: 91 | Existing positions closed: 63
17% more capital invested
Capital invested by funds: $14.1B → $16.5B (+$2.37B)
4% more funds holding
Funds holding: 598 → 622 (+24)
1.18% more ownership
Funds ownership: 99.92% → 101.1% (+1.2%)
5% less repeat investments, than reductions
Existing positions increased: 225 | Existing positions reduced: 237
29% less call options, than puts
Call options by funds: $163M | Put options by funds: $228M
75% less funds holding in top 10
Funds holding in top 10: 8 → 2 (-6)
Top Buyers
Top Sellers
PODD Hedge Fund Activity: Q3 2024 in Review
622 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q3 2024, worth a combined $16.5B — up 17% from $14.1B a quarter earlier.
Buyers outnumbered sellers: 91 funds opened new PODD positions and 63 closed out — a net gain of 28 holders — while 225 added to existing stakes and 237 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $414M. The largest seller was Wellington Management Group, cutting an estimated $143M.
- 622 institutional investors held Insulet (PODD) as of Q3 2024, up from 598 in Q2 2024.
- Funds reported $16.5B of Insulet stock for Q3 2024, up 17% quarter-over-quarter.
- 91 funds opened new Insulet positions in Q3 2024 and 63 closed out, a net change of +28 holders.
- The largest Insulet buyer in Q3 2024 was Fidelity Investments, an estimated $414M added.
- The largest Insulet seller in Q3 2024 was Wellington Management Group, an estimated $143M sold.
Based on aggregated 13F filings for Q3 2024.